1382486-27-2

Basic information

• Product Name: 1-(5-bromopyridin-2-yl)cyclobutanecarboxylic acid
• Synonyms: 1-(5-bromopyridin-2-yl)cyclobutanecarboxylic acid;1-(5-BROMOPYRIDIN-2-YL)CYCLOBUTANE-1-CARBOXYLIC ACID
• CAS NO: 1382486-27-2
• Molecular Formula: C₁₀H₁₀BrNO₂
• Molecular Weight: 256.0959
• EINECS: -0
• Mol File: 1382486-27-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 381.3±37.0 °C(Predicted)
• Appearance: /
• Density: 1.649±0.06 g/cm3(Predicted)
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 3.20±0.20(Predicted)
• CAS DataBase Reference: 1-(5-bromopyridin-2-yl)cyclobutanecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(5-bromopyridin-2-yl)cyclobutanecarboxylic acid(1382486-27-2)
• EPA Substance Registry System: 1-(5-bromopyridin-2-yl)cyclobutanecarboxylic acid(1382486-27-2)

Safety Data

• Hazardous Substances Data: 1382486-27-2(Hazardous Substances Data)

Usage

General Description

1-(5-bromopyridin-2-yl)cyclobutanecarboxylic acid is a chemical compound with the molecular formula C11H10BrNO2. It is a derivative of cyclobutanecarboxylic acid, with a 5-bromopyridin-2-yl moiety attached to the cyclobutane ring. 1-(5-bromopyridin-2-yl)cyclobutanecarboxylic acid may have potential applications in medicinal chemistry, particularly in the development of new pharmaceuticals or agrochemicals. The specific properties and uses of 1-(5-bromopyridin-2-yl)cyclobutanecarboxylic acid would depend on its exact chemical structure and any specific functional groups or properties it may possess.

Upstream product

• 624-28-2 2,5-dibromopyridine 
• 4426-11-3 cyclobutanecarbonitrile 
• 1382486-55-6 methyl 4-(5-bromopyridin-2-yl)oxane-4-carboxylate: 
• 485828-81-7 1-(5-bromopyridin-2-yl)cyclobutane-1-carbonitrile 

Relevant articles and documents

NOVEL SUBSTITUTED CYCLOBUTYLPYRIDINE AND CYCLOBUTYLPYRIMIDINE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS

Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: Also disclosed herein are uses of a compound disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of a composition in the potential treatment or prevention of an IDO-associated disease or disorder.

NOVEL SUBSTITUTED BIARYL COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS

Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: Also disclosed herein are uses of a compound disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of a composition in the potential treatment or prevention of an IDO-associated disease or disorder.